Latest News about FDA
Recent news which mentions FDA
Prospects for Full Approval of Eisai and Biogen's Leqembi Shine Brighter after FDA Committee Vote
June 12, 2023
From Benzinga
Drug Shortages in Focus: How FDA's Quest for New Methotrexate Suppliers Affects the Cancer Treatment Landscape
June 12, 2023
From Benzinga
Breakthrough in CRISPR-Based Therapy: FDA Accepts Vertex and CRISPR Therapeutics' Exa-cel Application
June 09, 2023
From Benzinga
Unanimous Support for AstraZeneca and Sanofi's Nirsevimab: Next Generation RSV Treatment on the Horizon
June 09, 2023
From Benzinga
From Benzinga
FDA Signals Support for Eisai-Biogen Alzheimer's Drug Data Confirms Benefits For Complete Approval
June 08, 2023
From Benzinga
Cue Health Becomes First Company to Receive FDA De Novo Authorization COVID-19 Home Use Test
June 07, 2023
Tickers
HLTH
From Benzinga
FDA Prioritizes GSK's Breakthrough Drug Jemperli for Endometrial Cancer Treatment, a First in Decades
June 06, 2023
Tickers
GSK
From Benzinga
Federal Psychedelics Reform Has More Lobbyists, Addiction Research Grant & Upcoming $27M VA Report
May 31, 2023
From Benzinga
From Benzinga
FDA Is Inaccurately Using Incomplete Safety Data On CBD To Refuse Regulation, Says Hemp Non-Profit
May 31, 2023
From Benzinga
FDA Presents Potential Framework For CBD, From Edibles To Delta-8, Reaffirms Congress Is In Charge
May 30, 2023
Tickers
JAZZ
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.